136 related articles for article (PubMed ID: 24484604)
1. Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.
de Araújo CF; Silva VM; Cronemberger-Andrade A; Aragão-França LS; Rocha VC; Santos PS; Pontes-de-Carvalho L
BMC Res Notes; 2014 Feb; 7():70. PubMed ID: 24484604
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds.
Silva VM; Larangeira DF; Oliveira PR; Sampaio RB; Suzart P; ; Nihei JS; Teixeira MC; Mengel JO; dos-Santos WL; Pontes-de-Carvalho L
Infect Immun; 2011 Mar; 79(3):1236-43. PubMed ID: 21173308
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.
Silva VM; de-Araújo CF; Navarro IC; Oliveira PR; Pontes-de-Carvalho L
BMC Res Notes; 2015 May; 8():197. PubMed ID: 25971623
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between vasodilation and Leishmania infection-enhancing effects of sand fly saliva and maxadilan.
Castro-Sousa F; Paranhos-Silva M; Sherlock I; Paixão MS; Pontes-de-Carvalho LC; dos-Santos WL
Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):997-9. PubMed ID: 11685268
[TBL] [Abstract][Full Text] [Related]
6. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
[TBL] [Abstract][Full Text] [Related]
7. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
8. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
10. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.
Grenfell RF; Marques-da-Silva EA; Souza-Testasicca MC; Coelho EA; Fernandes AP; Afonso LC; Rezende SA
Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):818-22. PubMed ID: 20944999
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Neutrophils and Leishmania braziliensis Amastigotes Facilitate Cell Activation and Parasite Clearance.
Carlsen ED; Jie Z; Liang Y; Henard CA; Hay C; Sun J; de Matos Guedes H; Soong L
J Innate Immun; 2015; 7(4):354-63. PubMed ID: 25766649
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lutzomyia whitmani (Diptera: Psychodidae) salivary gland lysates on Leishmania (Viannia) braziliensis infection in BALB/c mice.
Bezerra HS; Teixeira MJ
Mem Inst Oswaldo Cruz; 2001 Apr; 96(3):349-51. PubMed ID: 11313642
[TBL] [Abstract][Full Text] [Related]
13. Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.
Laurenti MD; Passero LF; Tomokane TY; Francesquini Fde C; Rocha MC; Gomes CM; Corbett CE; Silveira FT
Biomed Res Int; 2014; 2014():134236. PubMed ID: 25309902
[TBL] [Abstract][Full Text] [Related]
14. Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates:Callithricidae).
Cuba CA; Ferreira V; Bampi M; Magalhães A; Marsden PD; Vexenat A; De Mello MT
Mem Inst Oswaldo Cruz; 1990; 85(4):459-67. PubMed ID: 2152198
[TBL] [Abstract][Full Text] [Related]
15. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.
Costa DL; Carregaro V; Lima-Júnior DS; Silva NM; Milanezi CM; Cardoso CR; Giudice Â; de Jesus AR; Carvalho EM; Almeida RP; Silva JS
PLoS Negl Trop Dis; 2011 Mar; 5(3):e965. PubMed ID: 21390155
[TBL] [Abstract][Full Text] [Related]
16. Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice.
Lima HC; DeKrey GK; Titus RG
Mem Inst Oswaldo Cruz; 1999; 94(1):71-6. PubMed ID: 10029914
[TBL] [Abstract][Full Text] [Related]
17. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
18. Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice.
Indiani de Oliveira C; Teixeira MJ; Teixeira CR; Ramos de Jesus J; Bomura Rosato A; Santa da Silva J; Brodskyn C; Barral-Netto M; Barral A
Microbes Infect; 2004 Sep; 6(11):977-84. PubMed ID: 15345228
[TBL] [Abstract][Full Text] [Related]
19. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
[TBL] [Abstract][Full Text] [Related]
20. Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.
de Toledo JS; Junqueira dos Santos AF; Rodrigues de Moura T; Antoniazi SA; Brodskyn C; Indiani de Oliveira C; Barral A; Cruz AK
Parasitol Int; 2009 Mar; 58(1):45-50. PubMed ID: 18992366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
